Literature DB >> 28224049

The Role of Topical Antiseptic Agents Within Antimicrobial Stewardship Strategies for Prevention and Treatment of Surgical Site and Chronic Open Wound Infection.

Christopher D Roberts1, David J Leaper2, Ojan Assadian3.   

Abstract

Scope and Significance: The topical use of antiseptics for wound care has a role in an antimicrobial stewardship strategy. However, the details of this role need clarification. Further clinical research into the use of topical antiseptics in wound care would lower the risk of furthering antibiotic resistance and contribute to more effective antibiotic use. As part of this research, experimental and surveillance data are needed on the resistance and tolerance patterns associated with topical antiseptic use in wound infections. Objective: The development of antibiotic resistance presents global challenges in terms of patient harm and increased healthcare costs. The treatment of "at risk" and infected wounds contributes to this conundrum. Synergies between antibiotics and antiseptics and their appropriate combined use need exploration. Approach: A review of available evidence on the appropriateness of antiseptics as a fundamental component of antimicrobial stewardship strategies has been undertaken. Innovation: Opening up new ways of thinking and identifying gaps of knowledge will lead to optimizing justification of antimicrobial choices and combinations. This may lead to changes in practice in terms of solutions for the prevention and treatment of wound infection.
Conclusion: Antiseptics are an integral part of antimicrobial stewardship strategies for the prevention and treatment of surgical site and chronic open wound infections.

Entities:  

Keywords:  antibiotic resistance; antimicrobial stewardship; antiseptics; wound infection

Year:  2017        PMID: 28224049      PMCID: PMC5286547          DOI: 10.1089/wound.2016.0701

Source DB:  PubMed          Journal:  Adv Wound Care (New Rochelle)        ISSN: 2162-1918            Impact factor:   4.730


  27 in total

1.  Reliable surgical site infection surveillance with robust validation is required.

Authors:  J Tanner; M Kiernan; D Leaper; R Baggott
Journal:  J Hosp Infect       Date:  2013-05-24       Impact factor: 3.926

Review 2.  Topical antimicrobial therapy for treating chronic wounds.

Authors:  Benjamin A Lipsky; Christopher Hoey
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

Review 3.  Approach to chronic wound infections.

Authors:  D Leaper; O Assadian; C E Edmiston
Journal:  Br J Dermatol       Date:  2015-03-15       Impact factor: 9.302

4.  A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits.

Authors:  J Fong; F Wood; B Fowler
Journal:  Burns       Date:  2005-02-17       Impact factor: 2.744

Review 5.  Surgical site infection: poor compliance with guidelines and care bundles.

Authors:  David J Leaper; Judith Tanner; Martin Kiernan; Ojan Assadian; Charles E Edmiston
Journal:  Int Wound J       Date:  2014-02-25       Impact factor: 3.315

6.  A Comparison of Three Silver-containing Dressings in the Treatment of Infected, Chronic Wounds.

Authors:  Manuel Gago; Fernando Garcia; Victoriana Gaztelu; Jose Verdu; Pablo Lopez; Andreu Nolasco
Journal:  Wounds       Date:  2008-10       Impact factor: 1.546

7.  Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance.

Authors:  A Upton; S Lang; H Heffernan
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

8.  Randomized clinical trial of honey-impregnated dressings for venous leg ulcers.

Authors:  Andrew Jull; N Walker; V Parag; P Molan; A Rodgers
Journal:  Br J Surg       Date:  2008-02       Impact factor: 6.939

9.  A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds.

Authors:  E E Tredget; H A Shankowsky; A Groeneveld; R Burrell
Journal:  J Burn Care Rehabil       Date:  1998 Nov-Dec

10.  Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?

Authors:  David M Livermore; Russell Hope; Rosy Reynolds; Ruth Blackburn; Alan P Johnson; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2013-06-13       Impact factor: 5.790

View more
  10 in total

1.  Antiseptics for burns: a review of the evidence.

Authors:  L Slaviero; G Avruscio; V Vindigni; I Tocco-Tussardi
Journal:  Ann Burns Fire Disasters       Date:  2018-09-30

2.  In vitro cellular viability studies on a concentrated surfactant-based wound dressing.

Authors:  Rui Chen; Anne-Marie Salisbury; Steven L Percival
Journal:  Int Wound J       Date:  2019-03-20       Impact factor: 3.315

3.  Cytotoxicity and Wound Closure Evaluation in Skin Cell Lines after Treatment with Common Antiseptics for Clinical Use.

Authors:  Laura Ortega-Llamas; María I Quiñones-Vico; Marta García-Valdivia; Ana Fernández-González; Ana Ubago-Rodríguez; Raquel Sanabria-de la Torre; Salvador Arias-Santiago
Journal:  Cells       Date:  2022-04-20       Impact factor: 7.666

4.  A 2000 patient retrospective assessment of a new strategy for burn wound management in view of infection prevention and treatment.

Authors:  Justyna Glik; Wojciech Łabuś; Diana Kitala; Karolina Mikuś-Zagórska; Christopher D Roberts; Mariusz Nowak; Aleksandra Kasperczyk; Marek Kawecki
Journal:  Int Wound J       Date:  2017-12-15       Impact factor: 3.315

5.  Appropriate use of dressings containing nanocrystalline silver to support antimicrobial stewardship in wounds.

Authors:  Emma J Woodmansey; Christopher D Roberts
Journal:  Int Wound J       Date:  2018-08-17       Impact factor: 3.315

6.  Therapeutic response and safety of the topical, sequential use of antiseptic, keratolytic, and pentamidine creams (3-PACK) on Leishmania (Viannia) braziliensis-infected mice.

Authors:  Betsy Yaneth Muñoz; Julio Cesar Mantilla; Patricia Escobar
Journal:  Mem Inst Oswaldo Cruz       Date:  2019-05-13       Impact factor: 2.743

7.  Clinical impact of an anti-biofilm Hydrofiber dressing in hard-to-heal wounds previously managed with traditional antimicrobial products and systemic antibiotics.

Authors:  Daniel G Metcalf; Philip G Bowler
Journal:  Burns Trauma       Date:  2020-03-04

8.  Comparative in vitro evaluation of the antimicrobial activities of povidone-iodine and other commercially available antiseptics against clinically relevant pathogens.

Authors:  Eng Lee Tan; Nur Humaira Johari
Journal:  GMS Hyg Infect Control       Date:  2021-01-26

9.  Infections in Burn Patients: A Retrospective View over Seven Years.

Authors:  Savas Tsolakidis; David Lysander Freytag; Elisabeth Dovern; Ziyad Alharbi; Bong-Sung Kim; Khosrow Siamak Houschyar; Georg Reumuth; Benedikt Schäfer; Hans-Oliver Rennekampff; Norbert Pallua; Gerrit Grieb
Journal:  Medicina (Kaunas)       Date:  2022-08-08       Impact factor: 2.948

10.  Novel Bis-Ammonium Salts of Pyridoxine: Synthesis and Antimicrobial Properties.

Authors:  Nikita V Shtyrlin; Mikhail V Pugachev; Sergey V Sapozhnikov; Marsel R Garipov; Rusalia M Vafina; Denis Yu Grishaev; Roman S Pavelyev; Renata R Kazakova; Mariya N Agafonova; Alfiya G Iksanova; Svetlana A Lisovskaya; Marina I Zeldi; Elena S Krylova; Elena V Nikitina; Alina E Sabirova; Airat R Kayumov; Yurii G Shtyrlin
Journal:  Molecules       Date:  2020-09-22       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.